Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

MSCI to drop Swiggy from global indices on September 7

Global index providers MSCI and FTSE are set to revise Swiggy's index treatment shortly. MSCI is removing Swiggy from global indices, wh...